Myth-Historical CRISPR Edits

Abstract

History is not always written by the victors. Competing histories often become ssbattlegrounds for those who want to declare themselves victors. Emerging from the frontiers of molecular biology, today’s caustic patent dispute over gene-editing technology is being waged partly through published myth-histories. The revolutionary gene-editing technology CRISPR-Cas9 has quickly become a vehicle for patent and priority controversies to determine who cashes in on billions of dollars in licensing fees, a Nobel Prize, and scientific immortality. This chapter examines competing myth-histories in the context of larger socioeconomic forces, as well as the lack of an international regime of ethical guidelines for this work. Careful study is necessary to grasp the background and impact of these narratives.